Literature DB >> 12915619

Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.

Eva Moore1, Amy Wisniewski, Adrian Dobs.   

Abstract

Cross-sex hormone treatment is an important component in medical treatment of transsexual people. Endocrinologists are often faced with designing treatment recommendations. Although guidelines from organizations, such as the Harry Benjamin International Gender Dysphoria Association, have been helpful, management remains complex and experience guided. We discuss the range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment. Recommendations from seven clinical research centers treating transsexual people are discussed. In addition, self-reported hormonal regimens from 25 male-to-female transsexual people and five female-to-male transsexual people are reported. Finally, the potential adverse effects of cross-sex hormone treatment of transsexual people are reviewed. In light of the complexity of managing treatment goals and adverse effects, the active involvement of a medical doctor experienced in cross-sex hormonal therapy is vital to ensure the safety of transsexual people.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915619     DOI: 10.1210/jc.2002-021967

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

Review 1.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

2.  Structural Inequities and Social Networks Impact Hormone Use and Misuse Among Transgender Women in Los Angeles County.

Authors:  Kirsty Clark; Jesse B Fletcher; Ian W Holloway; Cathy J Reback
Journal:  Arch Sex Behav       Date:  2018-01-08

Review 3.  Gender identity and sport: is the playing field level?

Authors:  J C Reeser
Journal:  Br J Sports Med       Date:  2005-10       Impact factor: 13.800

4.  Gender abuse and major depression among transgender women: a prospective study of vulnerability and resilience.

Authors:  Larry Nuttbrock; Walter Bockting; Andrew Rosenblum; Sel Hwahng; Mona Mason; Monica Macri; Jeffrey Becker
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

5.  SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Authors:  A Godano; M Maggi; E Jannini; M C Meriggiola; E Ghigo; O Todarello; A Lenzi; C Manieri
Journal:  J Endocrinol Invest       Date:  2009-11       Impact factor: 4.256

6.  Health Disparities, Risk Behaviors and Healthcare Utilization Among Transgender Women in Los Angeles County: A Comparison from 1998-1999 to 2015-2016.

Authors:  Cathy J Reback; Kirsty Clark; Ian W Holloway; Jesse B Fletcher
Journal:  AIDS Behav       Date:  2018-08

7.  Adverse orthopedic effect of exogenous estrogens on men undergoing cross-gender hormonal therapy.

Authors:  Muhammad Adil Abbas Khan; Zain A Sobani; Mark Gorman
Journal:  Ther Adv Endocrinol Metab       Date:  2011-08       Impact factor: 3.565

Review 8.  Challenges in Transgender Healthcare: The Pathology Perspective.

Authors:  Sarika Gupta; Katherine L Imborek; Matthew D Krasowski
Journal:  Lab Med       Date:  2016-06-10

9.  Hormone and genetic study in male to female transsexual patients.

Authors:  F Lombardo; L Toselli; D Grassetti; D Paoli; P Masciandaro; F Valentini; A Lenzi; L Gandini
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

10.  Cross-sex hormonal replacement: is this really effective? an experimental clue.

Authors:  Natalia Pavón; Israel Pérez-Torres; Alberto Aranda; Francisco-Javier Roldán; Cristina Paredes; Edmundo Chávez
Journal:  Endocrine       Date:  2013-02-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.